Circulating Tumor DNA in High-Risk Stage II/III Cutaneous Melanoma: A Feasibility Study. Rhodin KE, O'Connor MH, Therien A, Hollander S, et al. Ann Surg Oncol 2025 Mar 27. doi: 10.1245/s10434-025-17194.

Read + Share

Amedeo Smart

Independent Medical Education

Rhodin KE, O'Connor MH, Therien A, Hollander S, et al. Circulating Tumor DNA in High-Risk Stage II/III Cutaneous Melanoma: A Feasibility Study. Ann Surg Oncol 2025 Mar 27. doi: 10.1245/s10434-025-17194.
PMID: 40146490